Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
Its a very good sign
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight - a substantial step up in potency from the existing crop of GLP-1 medicines
First, patients getting higher-than-intended doses often due to mislabeling or misunderstanding can experience severe nausea, vomiting, dehydration, and require urgent care
It was the precursor compound from which the more selective MC4R agonist Bremelanotide (PT-141) was derived
Some compounded versions may come in multi-dose vials with separate syringes
